A critical breakthrough in cancer study is emerging with the use of nanobodies to re-engage dysfunctional p53. This crucial tumor inhibitor protein is frequently inactivated in various kinds of tumors, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research